BOBULSKY SUSAN (SVP, Diagnostics, clonoSEQ) sold 8.8% of their position (41.34K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $544.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/13/2026ACC: 0001820885-26-000004
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
-41.34K
Net shares
Net seller
$544.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
41.34K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−41.34K
Price / share
$13.17
Trade value
$544.42K
% of position
8.8%
3/11/2026
469.11K→427.77K
Total
Net shares
−41.34K
Net value
-$544.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2026 | S · Sale | −41.34K | $13.17 | $544.42K | 8.8% | 469.11K | 427.77K |
| Total | −41.34K | -$544.42K | ||||||
Derivative Transactions0
No derivative transactions reported